Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
RO2-M52H3 | Mouse | Mouse ROR2 / NTRKR2 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
|
RO2-H82E3 | Human | Biotinylated Human ROR2 / NTRKR2 Protein, His,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
RO2-M5253 | Mouse | Mouse ROR2 / NTRKR2 Protein, Fc Tag | ![]() |
![]() ![]() |
|
RO2-H52E5 | Human | Human ROR2 / NTRKR2 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
RO2-H5251 | Human | Human ROR2 / NTRKR2 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
Immobilized Human ROR2, His Tag (Cat. No. RO2-H52E5) at 1 μg/mL (100 μL/well) can bind Anti-ROR2 Antibody, Human IgG1 with a linear range of 0.1-4 ng/mL (QC tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Ozuriftamab Vedotin | CAB-ROR2-ADC; CAB-ADC; CAB-ROR2; BA-3021; HTBA-3021 | Phase 2 Clinical | Bioatla | Solid tumours; Ovarian Neoplasms; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
CCT301-59 | CCT301-59 | Phase 2 Clinical | Bioatla, F1 Oncology | Solid tumours; Carcinoma, Renal Cell; Stomach Neoplasms; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Sarcoma | Details |
This web search service is supported by Google Inc.